tiprankstipranks
Nuvation Bio price target raised to $10 from $6 at RBC Capital
PremiumThe FlyNuvation Bio price target raised to $10 from $6 at RBC Capital
2M ago
Nuvation gets China NMPA approval for taletrectinib for ROS1-positive NSCLC
Premium
The Fly
Nuvation gets China NMPA approval for taletrectinib for ROS1-positive NSCLC
2M ago
FDA accepts Nuvation Bio’s NDA  for taletrectinib to treat ROS1+NSCLC
Premium
The Fly
FDA accepts Nuvation Bio’s NDA for taletrectinib to treat ROS1+NSCLC
2M ago
Nuvation Bio names Philippe Sauvage CFO
PremiumThe FlyNuvation Bio names Philippe Sauvage CFO
5M ago
Navigating Legal Uncertainty: Nuvation Bio Inc.’s Chinese Operations and the Shifting Landscape of China’s Civil Law System
Premium
Company Announcements
Navigating Legal Uncertainty: Nuvation Bio Inc.’s Chinese Operations and the Shifting Landscape of China’s Civil Law System
5M ago
Nuvation Bio price target lowered to $7 from $8 at H.C. Wainwright
Premium
The Fly
Nuvation Bio price target lowered to $7 from $8 at H.C. Wainwright
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100